When Executives Stop Selling Stock, a Big Deal Might Be Ahead

The Wall Street Journal2023-01-13

Investors learned ofAmgenInc.’s$28 billion bidforHorizon TherapeuticsPLC in December. But a clue to a potential deal emerged months earlier, when insiders in the target company stopped selling stock....

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
3